Loading clinical trials...
Loading clinical trials...
Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow and is the most common acute leukemia in adults. This study will evaluate how well Venetoclax works to treat AML in adult particip...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT05907057 · Acute Myeloid Leukemia (AML)
NCT07500441 · Acute Myeloid Leukemia (AML)
NCT05756777 · Acute Myeloid Leukemia (AML)
NCT05768932 · Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer, and more
NCT04990102 · Acute Myeloid Leukemia (AML) in Remission
Moscow State budget healthcare /ID# 218569
Moscow, Moscow
Saratov State Medical University n.a. V.I. Razumovskiy /ID# 226059
Saratov, Saratov Oblast
Hematology department State budgetary health care institution Volgograd region /ID# 229813
Volgograd, Volgograd Oblast
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions